指南与共识骨肌技术与安全US

欧洲抗风湿病联盟关于风湿与肌肉骨骼疾病超声研究报道的建议

EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs).
指南 / 共识 · Ann Rheum Dis · 2021-01-22

欧洲抗风湿病联盟(EULAR)工作组基于文献综述与专家意见(德尔菲调查),由23名成员制定、经79名外部专家评估,形成包含23个条目及术语表的超声研究报道清单,其中21项为必报条目、2项为条件适用时的选报条目,旨在提高研究结果的可解释性与适用性。

要点

  • EULAR清单要求RMD超声研究必报21项条目,涵盖盲法、评分系统开发、目标病变定义等。
  • 仅2项为选报条目,包括环境条件等混杂因素与超声操作者经验,适用时才报告。
  • 清单经79名外部专家评估可理解性、可行性与全面性,每条目以11分Likert量表评定共识。

核心结论

  • EULAR工作组制定清单以确保RMD超声研究在研究设计与操作程序方面得到透明全面的报道。
  • 作者认为该清单若被作者与编辑广泛采用,将大幅提高研究开发与结果的可解释性,包括有效性、通用性与适用性评估。

研究设计与样本

  • EULAR工作组由23名成员组成(12名RMD超声专家、9名方法与生物统计学专家,另有1名患者研究伙伴和1名风湿病学卫生专业人员)。
  • 方法基于文献综述与专家意见(通过德尔菲调查),并纳入79名外部专家(肌肉骨骼影像专家、方法学家、期刊编辑)评估清单的可理解性、可行性与全面性。
  • 每个条目的共识采用11分Likert量表评定,0分为完全不赞同、10分为完全赞同。

诊断标准与关键数值

  • 最终清单共23个条目,并包含术语表。
  • 21个条目为每项研究均须报告的「必报」条目,如盲法、评分系统的开发、目标病变的定义。
  • 2个条目为仅在适用时报告的「选报」条目,如可能的混杂因素(即环境条件)或超声操作者的经验。

临床应用与阅片要点

  • 作者认为该清单若被作者与编辑广泛采用,将大幅提高研究开发与结果的可解释性,包括有效性、通用性与适用性评估。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To produce European League Against Rheumatism (EULAR) recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs).

METHODS: Based on the literature reviews and expert opinion (through Delphi surveys), a taskforce of 23 members (12 experts in ultrasound in RMDs, 9 in methodology and biostatistics together with a patient research partner and a health professional in rheumatology) developed a checklist of items to be reported in every RMD study using ultrasound. This checklist was further refined by involving a panel of 79 external experts (musculoskeletal imaging experts, methodologists, journal editors), who evaluated its comprehensibility, feasibility and comprehensiveness. Agreement on each proposed item was assessed with an 11-point Likert scale, grading from 0 (total disagreement) to 10 (full agreement).

RESULTS: Two face-to-face meetings, as well as two Delphi rounds of voting, resulted in a final checklist of 23 items, including a glossary of terminology. Twenty-one of these were considered 'mandatory' items to be reported in every study (such as blinding, development of scoring systems, definition of target pathologies) and 2 'optional' to be reported only if applicable, such as possible confounding factors (ie, ambient conditions) or experience of the sonographers.

CONCLUSION: An EULAR taskforce developed a checklist to ensure transparent and comprehensive reporting of aspects concerning research and procedures that need to be presented in studies using ultrasound in RMDs. This checklist, if widely adopted by authors and editors, will greatly improve the interpretability of study development and results, including the assessment of validity, generalisability and applicability.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Costantino F, Carmona L, Boers M, et al. EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs). Ann Rheum Dis. 2021. PMID: 33483318. doi:10.1136/annrheumdis-2020-219816

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。